# US 2013/0253074 A1 · Implantation Material Comprising Biocompatible Polymer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253074 A1
- Document ID: US20130253074A1
- Status: Published application
- Kind: A1
- Application number: 13/848,841
- Filed: 2013-03-22
- Published: 2013-09-26
- Earliest claimed: 2012-03-26
- Assignees: Genewel Co., Ltd
- Applicants: Genewel Co., Ltd
- Inventors: Young Woo Lee; Wan Jin Cho; Ji Yeon Jang
- Web page: https://patentgrep.com/patent/US20130253074A1

## CPC

- C08B 37/0072: {Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates}
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- C07K 14/78: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C08B 37/0069: {Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof}
- C08B 37/0075: {Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof}
- C08B 37/0084: {Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates}
- C08H 1/00: Macromolecular products derived from proteins (food proteins A23; glue, gelatine C09H)
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C08H: DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS (polysaccharides C08B; natural rubber C08C; natural resins or their derivatives C09F; bituminous materials C10)

## Abstract

Disclosed herein is a hyaluronic acid epoxide derivative film comprises a polymer containing a hydroxyl (—OH) terminal group. The film is prepared by allowing an epoxy crosslinker to react with a mixture of hyaluronic acid and a polymer containing a hydroxyl (—OH) terminal group and has improved physical strength, in vivo stability, flexibility, adhesiveness to biological tissue, and biocompatibility.

## Claims

### Claim 1

A hyaluronic acid epoxide derivative film wherein a polymer containing a hydroxyl (—OH) terminal group is physically bonded to a crosslinked hyaluronic acid structure.

### Claim 2 (depends on 1)

The hyaluronic acid epoxide derivative film of claim 1, wherein the derivative film is comprised of 50-90 wt % of hyaluronic acid and 10-50 wt % of the polymer containing the hydroxyl (—OH) terminal group.

### Claim 3 (depends on 1)

The hyaluronic acid epoxide derivative film of claim 1, wherein the derivative film has a crosslinking density of 1-100 mole %.

### Claim 4 (depends on 1)

The hyaluronic acid epoxide derivative film of claim 1, wherein the polymer containing the hydroxyl (—OH) terminal group is one or more selected from the group consisting of polyethylene oxide, polyvinyl alcohol, polypropylene oxide, a polyethylene oxide-polypropylene oxide copolymer, a polyethylene oxide-polylactic acid copolymer, a polyethylene oxide-polylactic glycolic acid copolymer, a polyethylene oxide-polycaprolactone copolymer, polybutylene oxide, polyoxyethylene alkyl ethers, polyoxyethylene castor oil derivatives, polyoxyethylene sorbitan fatty acid esters, and polyoxyethylene stearates.

### Claim 5 (depends on 1)

The hyaluronic acid epoxide derivative film of claim 1, wherein the hyaluronic acid derivative is prepared by allowing an epoxide crosslinker to react with hyaluronic acid or hyaluronate alone or in combination with a polymer capable of forming an ether covalent bond with hyaluronic acid.

### Claim 6 (depends on 5)

The hyaluronic acid epoxide derivative film of claim 5, wherein the hyaluronate is one or more selected from the group consisting of sodium hyaluronate, potassium hyaluronate, calcium hyaluronate, magnesium hyaluronate, zinc hyaluronate, cobalt hyaluronate, and tetrabutylammonium hyaluronate.

### Claim 7 (depends on 5)

The hyaluronic acid epoxide derivative film of claim 5, wherein the polymer capable of forming the ether covalent bond with hyaluronic acid is one or more selected from the group consisting of hyaluronic acid, collagen, alginic acid, heparin, gelatin, elastin, fibrin, laminin, fibronectin, proteoglycan, heparan sulfate, chondroitin sulfate, dermatan sulfate, and keratin sulfate.

### Claim 8 (depends on 5)

The hyaluronic acid epoxide derivative film of claim 5, wherein the epoxide crosslinker is one or more selected from the group consisting of polyethylene glycol diglycidyl ether, 1,4-butanediol diglycidyl ether, ethylene glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, propylene glycol diglycidyl ether, poly(propylene glycol)diglycidyl ether), poly(tetramethylene glycol)diglycidyl ether, neopentyl glycol diglycidyl ether, polyglycerol polyglycidyl ether, diglycerol polyglycidyl ether, glycerol polyglycidyl ether, trimethylpropane polyglycidyl ether, 1,2-(bis(2,3-epoxypropoxy)ethylene), pentaerythritol polyglycidyl ether, and sorbitol polyglycidyl ether.

### Claim 9 (depends on 5)

The hyaluronic acid epoxide derivative film of claim 5, wherein the crosslinker is used in an amount of 1-100 parts by weight based on 100 parts by weight of repeating units of the hyaluronic acid.

### Claim 10 (depends on 1)

The hyaluronic acid epoxide derivative film of claim 1, wherein the derivative film is prepared by precipitation in an organic solvent after purification of the hyaluronic acid epoxide derivative.

### Claim 11 (depends on 1)

The hyaluronic acid epoxide derivative film of claim 1, wherein the derivative film is used as an adhesion barrier or a guided bone regeneration membrane.

### Claim 12 (depends on 11)

The hyaluronic acid epoxide derivative film of claim 11, wherein the derivative film further comprises an antibacterial and anti-inflammatory natural substance.
